The Impact of Immune Gene Polymorphisms in Kidney and Liver Transplantation

Clinics in Laboratory Medicine

Volumn 28, Issue 3, 2008, Pages 455-468

  Nickerson, Peter ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 10; LEUKOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALGORITHM; CELL INTERACTION; CELL MIGRATION; DNA POLYMORPHISM; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INTRON; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TISSUE INJURY;

ANTIGENS, CD80; ANTIGENS, CD86; CELL ADHESION MOLECULES; CHEMOKINES; CYTOKINES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 56349112398     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2008.09.003     Document Type: Review

References (71)

1. Meier-Kriesche H.U. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?. Am J Transplant 4 8 (2004) 1289-1295
2. Almond P.S., Matas A., Gillingham K., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 55 4 (1993) 752-756
3. Matas A.J., Gillingham K.J., Payne W.D., et al. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57 6 (1994) 857-859
4. Massy Z.A., Guijarro C., Wiederkehr M.R., et al. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 49 2 (1996) 518-524
5. McKenna R.M., Lee K.R., Gough J.C., et al. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation 66 1 (1998) 38-43
6. Shoskes D.A., and Cecka J.M. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66 12 (1998) 1697-1701
7. Nickerson P., Jeffery J., Gough J., et al. Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study. J Am Soc Nephrol 10 8 (1999) 1801-1805
8. Mahalati K., Belitsky P., Sketris I., et al. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 68 1 (1999) 55-62
9. Hutchinson I.V., Pravica V., and Sinnott P.J. Genetic regulation of cytokine synthesis: consequences for acute and chronic organ allograft rejection. Graft 1 (1998) 186-192
10. Altshuler D., Brooks L.D., Chakravarti A., et al. A haplotype map of the human genome. Nature 437 7063 (2005) 1299-1320
11. Halloran P.F. Interferon-gamma, prototype of the proinflammatory cytokines-importance in activation, suppression, and maintenance of the immune response. Transplant Proc 25 2 Suppl 1 (1993) 10-15
12. Pravica V., Asderakis A., Perrey C., et al. In vitro production of IFN-γ correlates with CA repeat polymorphism in the IFN-γ gene. Eur J Immunogenet 26 1 (1999) 1-3
13. Pravica V., Perrey C., Stevens A., et al. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61 9 (2000) 863-866
14. Pelletier R., Pravica V., Perry C., et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 70 4 (2000) 674-680
15. Dmitrienko S., Hoar D.I., Blashaw R., et al. Immune response gene polymorphisms in renal transplant recipients. Transplantation 80 12 (2005) 1773-1782
16. Hahn A.B., Kasten-Jolly J.C., Constantino D.M., et al. TNF-α, IL-6, IFN-γ, and IL-10 gene expression polymorphisms and the IL4 receptor α-chain variant Q576R: effects on renal allograft outcome. Transplantation 72 4 (2001) 660-665
17. Alakulppi N.S., Kyllonen L.E., Jantti V.T., et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation 78 10 (2004) 1422-1428
18. Asderakis A., Sankaran D., Dyer P., et al. Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 71 5 (2001) 674-678
19. Tinckam K., Rush D., Hutchinson I., et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 79 7 (2005) 836-841
20. Hoffman S., Park J., Jacobson L.M., et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 66 4 (2004) 1686-1693
21. Turner D., Grant S.C., Yonan N., et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 64 5 (1997) 776-779
22. Wilson A.G., Symons J.A., McDowell T.L., et al. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 7 (1997) 3195-3199
23. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism affects transcription. Mol Immunol 34 5 (1997) 391-399
24. Sankaran D., Asderakis A., Ashraf S., et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56 1 (1999) 281-288
25. Bathgate A.J., Pravica V., Perrey C., et al. The effect of polymorphisms in tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection. Transplantation 69 7 (2000) 1514-1517
26. Fernandes H., Koneru B., Fernandes N., et al. Investigation of promoter polymorphisms in the tumor necrosis factor-α and interleukin-10 genes in liver transplant patients. Transplantation 73 12 (2002) 1886-1891
27. Wrammer L.G., Norrby J., Hahn-Zoric M., et al. Impaired kidney graft survival is associated with the TNF-α genotype. Transplantation 78 1 (2004) 117-121
28. Nickerson P., Steiger J., Zheng X.X., et al. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?. Transplantation 63 4 (1997) 489-494
29. Chen W.F., and Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 147 2 (1991) 528-534
30. te Velde A.A., de Waal Malefijt R., Huijbens R.J., et al. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 149 12 (1992) 4048-4052
31. Turner D.M., Williams D.M., Sankaran D., et al. An investigation of polymorphisms in the interleukin-10 gene promoter. Eur J Immunogenet 24 1 (1997) 1-8
32. Xing Z., Gauldie J., Cox G., et al. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101 2 (1998) 311-320
33. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 7 (1998) 1369-1376
34. -174 promotor polymorphism is associated with long-term kidney allograft survival. Kidney Int 62 5 (2002) 1824-1827
35. Muller-Steinhardt M., Fricke L., Muller B., et al. Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572, and -174 on long-term kidney allograft survival. Am J Transplant 4 3 (2004) 402-406
36. Hackstein H., Kluter H., Frickle L., et al. The IL-4 receptor α-chain variant Q576R is strongly associated with decreased kidney allograft survival. Tissue Antigens 54 5 (1999) 471-477
37. Nelson P.J., and Krensky A.M. Chemokines, chemokine receptors, and allograft rejection. Immunity 14 4 (2001) 377-386
38. Ruster M., Sperschneider H., Funfstuck R., et al. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol 61 1 (2004) 30-39
39. Robertson H., Morley A.R., Talbot D., et al. Renal allograft rejection: beta-chemokine involvement in the development of tubulitis. Transplantation 69 4 (2000) 684-687
40. Fischereder M., Luckow B., Hocher B., et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 357 9270 (2001) 1758-1761
41. Shieh B., Liau Y.E., Hsieh P.S., et al. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol 12 9 (2000) 1311-1318
42. Schroppel B., Fischereder M., Lin M., et al. Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients. J Clin Immunol 22 6 (2002) 381-385
43. Abdi R., Huong T.T.B., Sahagun-Ruiz A., et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13 3 (2002) 754-758
44. Lee B., Doranz B.J., Rana S., et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 72 9 (1998) 7450-7458
45. Kruger B., Schroppel B., Ashkan R., et al. A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 13 10 (2002) 2585-2589
46. Schroppel B., Fischereder M., Ashkar R., et al. The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. Am J Transplant 2 7 (2002) 640-645
47. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259 2 (1999) 344-348
48. Nickel R.G., Casolaro V., Wahn U., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164 3 (2000) 1612-1616
49. An P., Nelson G.W., Wang L., et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A 99 15 (2002) 10002-10007
50. Kruger B., Boger C.A., Obed A., et al. RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clin Transplant 21 3 (2007) 385-390
51. Walunas T.L., Lenschow D.J., Bakker C.Y., et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 5 (1994) 405-413
52. Huang D., Giscombe R., Zhou Y., et al. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 105 1 (2000) 69-77
53. Kouki T., Sawai Y., Gardine C.A., et al. CTLA-4 gene polymorphisms at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165 11 (2000) 6606-6611
54. Slavcheva E., Albanis E., Jiao Q., et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute rejection. Transplantation 72 5 (2000) 935-940
55. Marder B.A., Schroppel B., Lin M., et al. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant 3 4 (2003) 424-431
56. de Reuver P., Pravica V., Hop W., et al. Recipient CTLA-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transplant 3 12 (2003) 1587-1594
57. Sharma V.K., Bologa R.M., Xu G.P., et al. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 49 5 (1996) 1297-1303
58. Cuhaci B., Kumar M.S., Bloom R.D., et al. Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 68 6 (1999) 785-790
59. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 3 (1998) 275-283
60. Bridoux F., Badou A., Saoudi A., et al. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J Exp Med 185 10 (1997) 1769-1775
61. Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 5176 (1994) 1237-1240
62. Eikmans M., Sijpkens Y.W., Baelde H.J., et al. High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 73 4 (2002) 573-579
63. Burlingham W.J., O'Connell P.J., Jacobson L.M., et al. Tumor necrosis factor-alpha and tumor growth factor-beta1 genotype: partial association with intragraft gene expression in two cases of long-term peripheral tolerance to a kidney transplant. Transplantation 69 7 (2000) 1527-1530
64. Lario S., Mendes D., Bescos M., et al. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation. Transplantation 75 10 (2003) 1647-1654
65. Reinders M.E., Sho M., Izawa A., et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112 11 (2003) 1655-1665
66. Shahbazi M., Fryer A.A., Pravica V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13 1 (2002) 260-264
67. Gunesacar R., Opelz G., Erken E., et al. VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Hum Immunol 68 7 (2007) 599-602
68. Renner W., Kotschan S., Hoffman C., et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37 6 (2000) 443-448
69. Lemos F.B.C., Mol W.M., Roodnat J.I., et al. The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation. Transplantation 79 9 (2005) 1221-1225
70. McLaren A.J., Marshell S.E., Haldar N.A., et al. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 55 5 (1999) 1977-1982
71. Marder B., Schroppel B., and Murphy B. Genetic variability and transplantation. Curr Opin Urol 13 2 (2003) 81-89